EP Patent

EP2475367A1 — NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES

Assigned to Centre National de la Recherche Scientifique CNRS · Expires 2012-07-18 · 14y expired

What this patent protects

The present invention relates to inhibitor of the activity of stearoyl-CoA-desaturase-1 (SCD-1) enzyme for use in the treatment of prostate cancer as well as to novel inhibitors of formula (IIa):

USPTO Abstract

The present invention relates to inhibitor of the activity of stearoyl-CoA-desaturase-1 (SCD-1) enzyme for use in the treatment of prostate cancer as well as to novel inhibitors of formula (IIa):

Drugs covered by this patent

Patent Metadata

Patent number
EP2475367A1
Jurisdiction
EP
Classification
—
Expires
2012-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Centre National de la Recherche Scientifique CNRS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.